| # | Drug | Count |
|---|---|---|
| 0 | METOCLOPRAMIDE HYDROCHLORIDE | 3273 |
| 1 | METOCLOPRAMIDE | 2870 |
| 2 | ERGOCALCIFEROL | 1295 |
| 3 | PREDNISONE | 1264 |
| 4 | METHOTREXATE SODIUM | 1228 |
| 5 | PREGABALIN | 1207 |
| 6 | ASPIRIN | 1149 |
| 7 | ASPIRIN 81 MG | 1119 |
| 8 | ASPIRIN 325 MG | 1117 |
| 9 | GABAPENTIN | 1117 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERGOCALCIFEROL | 1295 | 0.0436 |
| 1 | METOCLOPRAMIDE HYDROCHLORIDE | 3273 | 0.0421 |
| 2 | INFLIXIMAB-DYYB | 123 | 0.0357 |
| 3 | ZIPRASIDONE | 107 | 0.0297 |
| 4 | FOSCARBIDOPA/FOSLEVODOPA | 234 | 0.0265 |
| 5 | TETRABENAZINE | 189 | 0.0258 |
| 6 | GOLIMUMAB | 209 | 0.0166 |
| 7 | TRISODIUM CITRATE DIHYDRATE | 109 | 0.0159 |
| 8 | OXCARBAZEPINE | 246 | 0.0158 |
| 9 | SIPONIMOD | 113 | 0.0127 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3120 |
| 1 | Benzodiazepine [EPC] | 2320 |
| 2 | Corticosteroid [EPC] | 2315 |
| 3 | Atypical Antipsychotic [EPC] | 1634 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 1399 |
| 5 | Provitamin D2 Compound [EPC] | 1295 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 1202 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 1192 |
| 8 | Proton Pump Inhibitor [EPC] | 1186 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 1113 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 189 | 0.1524 |
| 1 | Interleukin-5 Antagonist [EPC] | 70 | 0.1017 |
| 2 | Provitamin D2 Compound [EPC] | 1295 | 0.0435 |
| 3 | Interleukin-17A Antagonist [EPC] | 818 | 0.0219 |
| 4 | Catechol-O-Methyltransferase Inhibitor [EPC] | 101 | 0.0200 |
| 5 | Paramagnetic Contrast Agent [EPC] | 90 | 0.0196 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 37 | 0.0178 |
| 7 | Nonergot Dopamine Agonist [EPC] | 231 | 0.0148 |
| 8 | Polymyxin-class Antibacterial [EPC] | 1 | 0.0137 |
| 9 | Nitrogen Binding Agent [EPC] | 27 | 0.0112 |